1st Quarter Results
August 10 2007 - 2:46AM
UK Regulatory
RNS Number:8771B
Nipro Corporation
10 August 2007
Summary Report of Consolidated Financial Results
For the Three Months Period ended June 30, 2007 (Year ending March 31, 2008)
August 10, 2007
Company name: NIPRO CORPORATION Code No.8086 TSE/OSE 1st section
URL: http://www.nipro.co.jp/
Representative:Minoru Sano, President and Representative Director
Contact: Akihiko Yamabe, Director, General Manager of Accounting &
Corporate Planning Division
TEL: (06) 6372-2331
(Note: Amounts are truncated to one million yen)
1. Financial results for the three months ended June 30, 2007.(From April 1,
2007 to June 30, 2007)
(1) Consolidated Results of Operations
Net Sales Operating Recurring Net(Quarter)
Income Income Income
Millions Millions Millions Millions
of yen % of yen % of yen % of yen %
3 months ended
June30,2007 41,376 (21.1) 3,757 (5.2) 4,684 38.3 2,964 82.5
3 months ended
June 30,2006 52,461 5.0 3,963 12.0 3,387 (4.4) 1,624 54.1
Year ended
March 31,2007 184,362 - 13,053 - 11,355 - 8,555 -
Earnings Diluted Earnings
per Share per Share
Yen Yen
3 months ended June 30,2007 46.69 -
3 months ended June 30,2006 25.57 -
Year ended March 31,2007 134.71 -
Note: The % displays show increase/decrease ratio against the same period of
the previous year.
(2) Consolidated Financial Position
Total Assets Net Assets Equity Ratio Net Assets per
Share
Millions Millions % Yen
of yen of yen
3 months ended
June 30,2007 344,868 129,468 37.1 2,017.58
3 months ended
June 30,2006 324,688 111,152 33.6 1,715.15
Year ended
March 31,2007 336,659 127,020 37.3 1,979.21
(3) Consolidated Cash Flows
Cash flows from Cash flows from Cash flows from Cash and
operating investing financing cash
activities activities activities equivalents
3 months Millions of yen Millions of yen Millions of yen Millions of yen
ended
June 30,2007 (2,023) (8,087) (2,875) 33,365
3 months
ended
June 30,2006 4,626 (4,986) (12,859) 36,772
Year ended
March 31,2007 14,488 (2,924) (15,654) 46,109
2. Projected Consolidated Financial Results for the Year ending March 31, 2008
(From April 1, 2007 to March 31, 2008)
The figures of the projected consolidated financial results for the year ending
March 31, 2008 (From April 1, 2007 to March 31, 2008) or for the six-month
period ending September 30, 2007, announced on May 18, 2007, have not been
changed.
3. Others
(1) Change in significant subsidiaries during the year ended June 30, 2007
(Resulting in a change in scope of consolidation): None
(2) Adoption of simplified accounting treatments: None
(3) Difference in the method of accounting treatment from the most recent fiscal
year: None
* Disclaimer regarding projection information including appropriate use of
forecasted financial results, and other special notes
The projection figures shown above are based on information that was available
at the time of preparation and may contain certain uncertainties. Actual
performance and other factors may differ from these projections due to changes
in circumstances and other developments.
(Qualitative information, financial statements and others)
1. Qualitative information on the consolidated results of operation
The situation of Japanese economy for this three-month period generally
remained in the trend of gradual expansion due to the steady individual
consumptions and capital investments, while we were afraid of a negative impact
from the continuous high oil prices and the rise of the interest rate. Under
such situation, we have made effort to reinforce our production capacity and
selling capability to enhance our revenues.
As a result, net sales for the three months ended June 30, 2007 was 41,376
million yen, decreased by 21.1% from the same period of the previous fiscal year
due to no sales from store business, which had the sales of 16,127 million yen
in the same period of the previous fiscal year but we withdrew from the retail
division in the previous fiscal period. The sales of Medical Equipment business
was 26,440 million increased by 17.1% from the same period of the previous
fiscal year, the sales of Pharmaceutical business was 12,060 million yen
increased by 22.1% from the same period of the previous fiscal year, the sales
of Glass and Materials business was 2,660 million yen decreased by 25.0% from
the same period of the previous fiscal year, and the sales of other business was
215 million yean decrease by 35.6% from the same period of the previous fiscal
year.
Operating income decreased by 5.2% from the same period of the previous fiscal
year to 3,757 million yen, while recurring income increased by 38.3% from the
same period of the previous fiscal year to 4,684 million yen due to the accrual
of foreign exchange gain and net quarter income increased by 82.5% from the same
period of the previous fiscal year to 2,964 million yen.
2. Qualitative information on the consolidated financial position
Total assets increased by 8,209 million yen to 344,868 million yen from the
end of previous fiscal year. Current assets decreased by 7,916 million yen and
fixed assets increased by 16,125 million yen from the end of previous fiscal
year. Current assets decreased mainly due to the decrease of 12,746 million yen
in the cash on hand in banks and fixed assets decreased mainly due to the
increase of 12,559 million yen in the tangible fixed assets.
Total liabilities increased by 5,761 million yen to 215,400 million yen.
Current liabilities increased by 16,327 million yen and fixed liabilities
decreased by 10,565 million yen. Current liabilities increased mainly due to
increase of 10,000 million yen in current portion of bonds and fixed liabilities
decreased mainly due to decrease of 10,000 million yen in bonds.
Net assets increased by 2,447 million yen to 129,468 million yen from the end
of previous fiscal year.
3. Qualitative information on the state of the consolidated cash flow
Cash flow used in operating activities amounted to 2,023 million yen mainly
reflecting income taxes paid, cash flow used in investing activity amounted to
8,087 million yen mainly due to payments for acquisition of fixed assets for
8,324 million yen, and cash flow used in financing activities also amounted to
2,875 million yen of payment exceeds mainly due to repayment of long-term
borrowings. As a result, cash and cash equivalents at the end of the period
amounted to 33,365 million yen decreased by 12,744 million yen from the end of
previous fiscal year.
4. Qualitative information on the projected consolidated financial
results
The business environment is anticipated to remain severe due to worry about
rise of oil prices and increase of interest rates. We, however, continuously
endeavor to develop new products, as well as to reinforce the production
capacity and selling capability in order to enhance our revenues.
Thus, the figures of the projected consolidated financial results for the year
ending March 31, 2008 (From April 1, 2007 to March 31, 2008) announced on May
18, 2007, have not been changed.
5. Others
(1) Change in significant subsidiaries during the year ended June 30, 2007
(Resulting in a change in scope of consolidation): None
(2) Adoption of simplified accounting treatments: None
(3) Difference in the method of accounting treatment from the most recent fiscal
year: None
This information is provided by RNS
The company news service from the London Stock Exchange
END
QRFGRGDICXBGGRG
Nipro 0cpn 23 (LSE:84ZB)
Historical Stock Chart
From Nov 2024 to Dec 2024
Nipro 0cpn 23 (LSE:84ZB)
Historical Stock Chart
From Dec 2023 to Dec 2024
